Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphatic Metastasis × Technetium × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphatic Metastasis 1 Lung Neoplasms 1 Breast Neoplasms 1

Interventions

TP protocol 2 pembrolizumab 1 cabozantinib 1 Technetium 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radiotherapy, Adjuvant 1 Radiotherapy 1 Paclitaxel 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Indocyanine Green 1 Control Groups 1 Cobalt-60 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Chemoradiotherapy 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04233476 2024-07-01

TRIIL

RDO Pharm.

Phase 3 Completed

Lung Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡